233 related articles for article (PubMed ID: 21679311)
1. MRD analysis and treatment outcome in three children with SET-NUP214-positive hematological malignancies.
Li WJ; Cui L; Gao C; Zhao XX; Liu SG; Xing YP; Zhang RD; Zhang DW; Wang B; Li ZG; Wu MY
Int J Lab Hematol; 2011 Dec; 33(6):e25-7. PubMed ID: 21679311
[No Abstract] [Full Text] [Related]
2. [Gene rearrangement pattern of immunoglobulin and T-cell receptor (Ig/TR) and its clinical characteristics in children with SET-NUP214 fusion gene-positive leukemia/lymphoma].
Li WJ; Cui L; Gao C; Zhao XX; Liu SG; Xin YP; Zhang RD; Zhang DW; Wang B; Li ZG; Wu MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1362-7. PubMed ID: 22169284
[TBL] [Abstract][Full Text] [Related]
3. T-cell acute lymphoblastic leukemia associated with complex karyotype and SET-NUP214 rearrangement: a case study and review of the literature.
Lee SG; Park TS; Cho SY; Lim G; Park GJ; Oh SH; Cho EH; Chong SY; Huh JY
Ann Clin Lab Sci; 2011; 41(3):267-72. PubMed ID: 22075511
[TBL] [Abstract][Full Text] [Related]
4. Infant acute bilineal leukemia.
Derwich K; Sedek L; Meyer C; Pieczonka A; Dawidowska M; Gaworczyk A; Wachowiak J; Konatkowska B; Witt M; Marschalek R; Szczepański T
Leuk Res; 2009 Jul; 33(7):1005-8. PubMed ID: 19286255
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of MRD-dynamics in childhood acute lymphoblastic leukemia treated according to the MB-2002/2008 protocols.
Meleshko AN; Savva NN; Fedasenka UU; Romancova AS; Krasko OV; Eckert C; von Stackelberg A; Aleinikova OV
Leuk Res; 2011 Oct; 35(10):1312-20. PubMed ID: 21596436
[TBL] [Abstract][Full Text] [Related]
6. The characteristics and prognostic significance of the SET-CAN/NUP214 fusion gene in hematological malignancies: A systematic review.
Wang J; Zhan QR; Lu XX; Zhang LJ; Wang XX; Zhang HY
Medicine (Baltimore); 2022 Jul; 101(30):e29294. PubMed ID: 35905214
[TBL] [Abstract][Full Text] [Related]
7. [Expression of SET-NUP214 fusion gene in patients with T-cell acute lymphoblastic leukemia and its clinical significance].
Dai HP; Wang Q; Wu LL; Ping NN; Wu CX; Xie JD; Pan JL; Xue YQ; Wu DP; Chen SN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1047-51. PubMed ID: 23114116
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and genetic characterization of adult T-cell acute lymphoblastic leukemia with del(9)(q34);SET-NUP214 rearrangement.
Chae H; Lim J; Kim M; Park J; Kim Y; Han K; Lee S; Min WS
Ann Hematol; 2012 Feb; 91(2):193-201. PubMed ID: 21720744
[TBL] [Abstract][Full Text] [Related]
9. SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines.
Quentmeier H; Schneider B; Röhrs S; Romani J; Zaborski M; Macleod RA; Drexler HG
J Hematol Oncol; 2009 Jan; 2():3. PubMed ID: 19166587
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the clinical characteristics of 24 cases of hematological malignancies with SET-NUP214 fusion gene].
Chen SM; Song WJ; Qin YZ; Wang Z; Dang H; Shi Y; He Q; Jiang Q; Jiang H; Huang XJ; Lai YY
Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):459-465. PubMed ID: 34384151
[No Abstract] [Full Text] [Related]
11. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
12. Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11)(p12;q23);MLL-MLLT10.
Lou Z; Zhang CC; Tirado CA; Slone T; Zheng J; Zaremba CM; Oliver D; Chen W
Leuk Res; 2010 Aug; 34(8):1107-9. PubMed ID: 20299091
[TBL] [Abstract][Full Text] [Related]
13. Molecular monitoring in NUP214-ABL-positive T-acute lymphoblastic leukemia reveals clonal diversity and helps to guide targeted therapy.
Koschmieder S; Burmeister T; Brüggemann M; Berkemeier A; Volpert S; Wieacker P; Silling G; Gökbuget N; Müller-Tidow C; Berdel WE; Stelljes M
Leukemia; 2014 Feb; 28(2):419-22. PubMed ID: 24048416
[No Abstract] [Full Text] [Related]
14. Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.
Wang Q; Qiu H; Jiang H; Wu L; Dong S; Pan J; Wang W; Ping N; Xia J; Sun A; Wu D; Xue Y; Drexler HG; Macleod RA; Chen S
Haematologica; 2011 Dec; 96(12):1808-14. PubMed ID: 21880637
[TBL] [Abstract][Full Text] [Related]
15. Post-induction residual disease in translocation t(12;21)-positive childhood ALL.
Seyfarth J; Madsen HO; Nyvold C; Ryder LP; Clausen N; Jonmundsson GK; Wesenberg F; Schmiegelow K
Med Pediatr Oncol; 2003 Feb; 40(2):82-7. PubMed ID: 12461790
[TBL] [Abstract][Full Text] [Related]
16. Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.
Deenik W; Beverloo HB; van der Poel-van de Luytgaarde SC; Wattel MM; van Esser JW; Valk PJ; Cornelissen JJ
Leukemia; 2009 Mar; 23(3):627-9. PubMed ID: 18987655
[No Abstract] [Full Text] [Related]
17. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis.
Foroni L; Harrison CJ; Hoffbrand AV; Potter MN
Br J Haematol; 1999 Apr; 105(1):7-24. PubMed ID: 10366253
[No Abstract] [Full Text] [Related]
18. SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALL.
Ben Abdelali R; Roggy A; Leguay T; Cieslak A; Renneville A; Touzart A; Banos A; Randriamalala E; Caillot D; Lioure B; Devidas A; Mossafa H; Preudhomme C; Ifrah N; Dombret H; Macintyre E; Asnafi V
Blood; 2014 Mar; 123(12):1860-3. PubMed ID: 24449214
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of SET-NUP214 fusion gene in acute leukemia after allogeneic hematopoietic stem cell transplantation.
Gao MG; Hong Y; Qin YZ; Chang YJ; Wang Y; Zhang XH; Xu LP; Huang XJ; Zhao XS
Medicine (Baltimore); 2020 Dec; 99(50):e23569. PubMed ID: 33327316
[TBL] [Abstract][Full Text] [Related]
20. [The minimal residual disease (MRD) in hematological malignancies].
Yokota S; Okamoto T
Gan To Kagaku Ryoho; 2001 Jun; 28(6):762-8. PubMed ID: 11432342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]